Delayed-type hypersensitivity responses to Mycobacterium paratuberculosis purified protein derivative (PPD) were decreased in cows experimentally exposed to M. paratuberculosis 7 days after exposure to a modified-live bovine viral diarrhea virus (ML-BVDV) vaccine. In vitro lymphocyte blastogenic responses to phytohemagglutinin were decreased in each of 3 cows 7 days after exposure to ML-BVDV vaccine. Also, decreased lymphocyte blastogenic responses to M. paratuberculosis PPD were observed in cultures of 2 of 3 cows 7 days after exposure to ML-BVDV vaccine. No significant differences in enzyme-linked immunosorbent assay reactions were detected in sera of M. paratuberculosis-infected cattle collected before and at 4 and 12 weeks after exposure to ML-BVDV vaccine.
Johne's disease (paratuberculosis) continues to cause important economic losses to dairy and beef producers in Iowa and in widespread areas of the United States 11, 17, 19 Production losses are mainly related to premature culling of animals with clinical and subclinical Johne's disease. In some high-producing dairy herds, reports indicate milk production may decrease ≥ 20% in animals with clinical disease. 1,3,4 Progress has been made toward minimizing losses due to Johne's disease in some individual herds in Iowa in which control measures have been employed for ≥6 years. 19 Information from field investigations indicate that an increased number of clinical cases of Johne's disease is observed in herds in which Mycobacterium paratuberculosis infection persists following outbreaks of bovine viral diarrhea virus (BVDV) or after vaccination with modified-live BVDV (ML-BVDV) (Dr. Larry Moore, personal communication). Alterations in polymorphonuclear leukocyte function have been reported in cattle exposed to virulent BVDV. 14 Also, it has been reported that an ML-BVDV caused a depression of lymphocyte blastogenic response to selected mitogens as well as a significant suppression of neutrophil iodination and antibody-dependent cell-mediated cytotoxicity. 12, 13 However, no definitive information is available on cell-mediated responses to specific mycobacterial antigens or mononuclear cell function in cattle with Johne's disease after exposure to ML-BVDV vaccine.
The purposes of this investigation were to obtain information on delayed-type hypersensitivity skin responses to a purified protein derivative (PPD) of Mycobacterium paratuberculosis, to determine in vitro lymphocyte blastogenic responses to phytohemagglutinin or to M. paratuberculosis PPD, and to determine enzyme-linked immunosorbent assay (ELISA) reactions of sera from cattle exposed orally to M. paratuberculosis before and after intramuscular injection of a noncytopathic ML-BVDV vaccine.
Materials and methods
Animals. Eight heifer calves negative on skin tests, using M. paratuberculosis PPD, from herds in which paratuberculosis had not been diagnosed for 23 yr were used. Six calves were each orally exposed to live M. paratuberculosis (200 mg wet weight of a 7-wk-old culture) at 2 mo of age. 16 Two calves not exposed to M. paratuberculosis were included as controls. At 43 mo of age, the 6 cows exposed to M. paratuberculosis were randomly divided into 2 groups (3 cows per group). No significant serum neutralization titers to BVDV were detected in sera of these cows. Group I animals were injected with saline and maintained as controls. Group II animals were each injected intramuscularly with a noncytopathic ML-BVDV vaccine (4 x l0 4 cell culture infective doses).
Delayed-type hypersensitivity skin tests. Skin tests were conducted before and at 7 and 63 days after exposure to ML-BVDV vaccine, using a M. paratuberculosis PPD injected intradermally on the side of the neck. Skin thickness was measured using calipers before and 72 hr following injection, and any increase in skin thickness (mm) was determined.
Lymphocyte blastogenic assays (LBA). Blood samples were collected from all cows before and at 1 and 2 wk after exposure to ML-BVDV vaccine and from the controls. Blood was placed in siliconized 20-x 150-mm sterile culture tubes containing acid-citrate dextrose solution (ACD). Blood was suspended in an equal volume of phosphate buffered saline (PBS), pH 7.2; the blood cell suspension was layered over ficoll-diatrizoate a and centrifuged at 400 x g for 40 min at 22 C. The lymphocyte-rich layer was removed, and the cells were resuspended and washed twice with Hank's Balanced Salt Solution. b The mononuclear cell concentration was determined, and the cells were resuspended in medium M199 b containing 25 mM HEPES b penicillin (200 U/ml), streptomycin (200 µg/ml), b 15% fetal bovine serum, c and 5 x 10-5 M 2-mercaptoethanol. a Cells were cultured alone or incubated with phytohemagglutinin (PHA) d (250 or 100 ng/well) or M. paratuberculosis PPD e (1, 10, or 20 µg/well) in flatbottomed microtiter plates f (5 x 10 5 cells in 200 µ1). Cell cultures were conducted in triplicate. Cells cultured alone or incubated with PHA were harvested after 66 hr. Cells cultured alone or incubated with M. paratuberculosis PPD were harvested after 114 hr. All cultures were incubated at 37 C in a 5% CO, humidifed atmosphere. Eighteen hours prior to harvest, 1 µCi of 3 H-thymidine g (specific activity, 5 Ci/mmole) was added to each culture. Cells were harvested onto glass fiber filters using a Skatron Cell Harvester." Radioactivity was measured in a liquid scintillation spectrometer. h The mean counts per minute (CPM) of the triplicate cultures of the lymphocytes incubated with PHA or M. paratuberculosis PPD were divided by the mean CPM of the cells cultured alone.
ELISA. Sera were harvested from blood collected from cattle before exposure and at 4 and 12 wk after exposure to ML-BVDV vaccine and from controls at the same time intervals. Fifty microliters of carbodiimide a (1 mg/ml) diluted in 0.1 M Na 2 CO 3 and 50 µ1 M. paratuberculosis PPD diluted in Na 2 CO 3 were added to each well. Fifty microliters of potassium chloride extract of M. paratuberculosis (100 µg/well) and 50 µ1 of carbodiimide were added to each well of separate plates. 6 The plates containing the PPD or KC1 antigen extract were incubated at 4 C for 16 hr and washed 3 times with PBS. Then 100 µ1 of 0.1 M NH 4 Cl was added to each well and incubated at 22 C for 30 min. The plates were washed 3 times using PBS containing 0.5% Tween 80. Fifty microliters of serum diluted 1:40 in PBS containing 1% Tween 80 and 1% bovine serum albumin (BSA) was added to the first well; 2-fold dilutions of serum were added to separate wells. After incubation for 30 min on a horizontal shaker i at 22 C, the plates were washed 8 times with PBS containing 0.5% Tween 80 adjusted to pH 7.5 with 1 M NaOH. Fifty microliters of goat anti-bovine IgG, heavy-and light-chain specific, labeled with horseradish peroxidase was added to each well and incubated for 30 min at 22 C on the shaker. The plates were washed 8 times with wash solution. A substrateindicator solution of hydrogen peroxide and 2,2-azino-di (3 ethyl benzthiazoline-6-sulfonate) in 0.05 M citric acid (pH 4.0) was added to each well. The plates were incubated at 22 C. The color intensity of the reactions was determined at 1 hr, using a microplate reader at a wavelength of 405 nm. k
Results
Results of delayed-type hypersensitivity skin tests revealed a decrease in response to M. paratuberculosis Table 1 . Results of delayed-type hypersensitivity tests in 3 cows exposed to Mycobacterium paratuberculosis (group I), 3 cows exposed to M. paratuberculosis after exposure to ML-BVDV vaccine (group II), and noninfected controls (group III).
Skin test response (mm)* Postexposure PPD at 7 days postinjection of ML-BVDV vaccine (Table 1) . However, no important differences in skin test responses were observed 63 days postexposure to ML-BVDV vaccine as compared with preinjection responses or with values of the controls. Six days following injection of ML-BVDV vaccine, 1 animal (no. 205) developed diarrhea that persisted for 27 days. No skin test responses were detected to M. paratuberculosis PPD in the 2 controls not exposed to M. paratuberculosis.
Responses to PHA were detected in each of the cell suspensions collected before and at 1 and 2 weeks after exposure to ML-BVDV vaccine and in cattle not exposed to M. paratuberculosis ( Table 2 ). The LBA responses to PHA were markedly decreased in each of the 3 cows receiving ML-BVDV vaccine as compared with responses in cattle not receiving the vaccine. The LBA responses to PHA obtained at 2 weeks postexposure to ML-BVDV vaccine were similar to preexposure values and to values of cattle not exposed to M. paratuberculosis. No important differences were detected in LBA values of animals receiving ML-BVDV vaccine at 2 weeks as compared with controls.
The LBA responses to specific mycobacterial antigens were decreased for each of 2 cows (nos. 37 and 205) 7 days postexposure to ML-BVDV vaccine (Table  3) . At 2 weeks postexposure, the in vitro responses to M. paratuberculosis PPD returned to values obtained before ML-BVDV vaccine injection. No positive LBA responses to M. paratuberculosis PPD were detected in controls.
A comparison of ELISA reactions revealed no consistent differences on sera collected before or at 4 and 12 weeks after exposure to ML-BVDV vaccine, using a KC1 extract of M. paratuberculosis or a PPD of M. Table 2 . Results of lymphocyte blastogenic assays using phytahemagglutinin and cells of 3 cows exposed to Mycobacterium paratuberculosis (group I), 3 cows exposed to M. paratuberculosis after exposure to a ML-BVDV vaccine (group II), and noninfected controls (group III).
Stimulation index* paratuberculosis as antigens (Table 4) . No significant ELISA reactions were observed in sera of controls.
Discussion
Bovine virus diarrhea virus is widespread in dairy and beef cattle; therefore vaccination is a common practice. Although killed vaccines are currently available, ML-BVDV vaccines have been widely used. Previous reports revealed that lymphocyte response to phytahemagglutinin, polkweed mitogen, or to concanavalin A was altered in cattle following injection of ML-BVDV vaccine. l3 Similar findings have been reported in cattle infected with virulent BVDV. 8,12 Re- Table 3 . Results of lymphocyte blastogenic assays using Mycobacterium paratuberculosis PPD and cells of 3 cows exposed to M. paratuberculosis (group I), 3 cows exposed to M. paratuberculosis after exposure to a ML-BVDV vaccine (group II), and noninfected controls (group III). Table 4 . Results of enzyme-linked immunosorbent assays (ELISA) conducted on sera of 3 cows exposed to Mycobacterium paratuberculosis (group I), 3 cows exposed to M. paratuberculosis after exposure to ML-BVDV vaccine (group II), and noninfected controls (group III). sults of this study provide further evidence that certain in vitro mononuclear cell responses are altered following administration of a noncytopathic strain of ML-BVDV vaccine. Moreover, data presented indicate cellmediated responses to certain mycobacteria1 antigens were altered. The exact mechanism involved is unclear. However, this may be related to reduction in certain lymphocyte subpopulations or to the influence of cytokines (i.e., interleukins) on mononuclear cell function. 2 The data suggest that antimycobacterial antibody levels in serum are not significantly altered following exposure to a ML-BVDV vaccine. This is of practical significance because an ELISA is used in detecting M. paratuberculosis-infected animals in herds in which Johne's disease persists. 5,7 Systematic investigations are necessary to obtain information on the influence of ML-BVDV on the development of specific immune responses of cattle to mycobacteria1 antigens.
Stimulation index*
The pathogenesis of M. paratuberculosis infection in cattle is poorly understood. 18 Young cattle are more susceptible than adult animals. 9 Paratuberculosis is transmitted mainly by exposure of calves to M. paratuberculosis during nursing or by ingestion of contaminated feed and water; l7 however, bovine fetal infection with M. paratuberculosis may occur. 10, 15, 20 Additional investigations are needed to elucidate the role of virulent BVDV in modulating immune responses and altering the susceptibility of calves and adult cattle to M. paratuberculosis following outbreaks of BVDV. acknowledge the technical assistance of S. A. Duchman. This work was supported in part by the US Department of Agriculture, Washington, DC.
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